Netcapital to host planned Reg A offering by Algernon NeuroScience

Netcapital (NCPL) announced that its subsidiary, Netcapital Securities, a FINRA-registered broker-dealer, has been engaged by Algernon NeuroScience (AGNPF) for its planned Regulation A offering. Netcapital Securities plans to provide broker-dealer and administrative services, excluding underwriting and placement agent services, in connection with this offering. Algernon NeuroScience has filed a Form 1-A with the U.S. Securities and Exchange Commission, though the offering has not yet been qualified or declared effective by the SEC. Algernon intends to use proceeds from the offering to advance its R&D initiatives.